|
Volumn 21, Issue 4, 2015, Pages 583-588
|
Guidelines for defining and implementing standard episode of care for hematopoietic stem cell transplantation within the context of clinical trials
c
OPTUM
(United States)
d
Cigna
(United States)
|
Author keywords
Affordable Care Act; Clinical trials; Costs; Hematopoietic cell transplantation; Routine care; Standard of care
|
Indexed keywords
ARTICLE;
CLINICAL RESEARCH;
CLINICAL TRIAL (TOPIC);
COURSE EVALUATION;
FOLLOW UP;
HEALTH CARE POLICY;
HEALTH CARE QUALITY;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
PATIENT CARE;
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRACTICE GUIDELINE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TRANSPLANTATION;
COST;
ECONOMICS;
PROCEDURES;
STANDARDS;
CLINICAL TRIALS AS TOPIC;
COSTS AND COST ANALYSIS;
GUIDELINES AS TOPIC;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
|
EID: 84924237100
PISSN: 10838791
EISSN: 15236536
Source Type: Journal
DOI: 10.1016/j.bbmt.2014.12.030 Document Type: Article |
Times cited : (15)
|
References (2)
|